DUBLIN/NEW YORK (Reuters) - Royalty Pharma on Friday raised its hostile bid for Irish drug firm Elan to a potential $8 billion, the third increase in five months.




Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/02yFPC5d_Iw/story01.htm
phlebotomy school school phlebotomy phlebotomist school
No comments:
Post a Comment